American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Heron Therapeutics, Inc.

HRTX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

HRTX historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of HRTX by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 02, 2022
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 28, 2021
Ashley Hinson House / R Sale $1,001 - $15,000 Mar 31, 2021
HRTX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
HRTX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
HRTX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in HRTX holdings by institutional investors

Insider Trading

Quarterly net insider trading by HRTX's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $50,000 Jul 20, 2026 Issue: Health Issues Medicare/Medicaid
  • $50,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid
  • $50,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid
  • $50,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid
  • $50,000 Jul 21, 2025 Issue: Health Issues Medicare/Medicaid
  • $50,000 Apr 21, 2025 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid
  • $50,000 Oct 21, 2024 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jul 18, 2024 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jan 22, 2024 Issue: Medicare/Medicaid Health Issues
  • $50,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jul 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jan 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $50,000 Oct 28, 2022 Issue: Medicare/Medicaid Health Issues
  • $50,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jul 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $50,000 Apr 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $50,000 Jul 14, 2021 Issue: Health Issues Medicare/Medicaid
  • $50,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $50,000 Jan 19, 2021 Issue: Medicare/Medicaid Health Issues
  • $50,000 Oct 19, 2020 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $50,000 Apr 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jan 22, 2020 Issue: Pharmacy Health Issues Medicare/Medicaid
  • $50,000 Oct 18, 2019 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jul 18, 2019 Issue: Medicare/Medicaid Health Issues
  • $50,000 Apr 17, 2019 Issue: Medicare/Medicaid Health Issues
  • $50,000 Apr 15, 2019 Issue: None
  • $50,000 Jan 16, 2019 Issue: Pharmacy Medicare/Medicaid Health Issues
  • $50,000 Jan 15, 2019 Issue: Medicare/Medicaid
  • $50,000 Oct 18, 2018 Issue: Pharmacy Health Issues Medicare/Medicaid
  • $50,000 Oct 18, 2018 Issue: Medicare/Medicaid
  • $50,000 Jul 19, 2018 Issue: Health Issues Pharmacy Medicare/Medicaid
  • $50,000 Jul 19, 2018 Issue: Medicare/Medicaid
  • $40,000 Apr 18, 2018 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $40,000 Jan 11, 2018 Issue: Medicare/Medicaid Health Issues Pharmacy
  • $40,000 Nov 20, 2017 Issue: Pharmacy
  • $40,000 Nov 20, 2017 Issue: Pharmacy
  • $40,000 Oct 19, 2017 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $30,000 Jan 23, 2017 Issue: Pharmacy
  • $15,000 Jan 18, 2017 Issue: Health Issues
  • $30,000 Oct 20, 2016 Issue: Pharmacy
  • $15,000 Oct 19, 2016 Issue: Health Issues
  • $30,000 Jul 20, 2016 Issue: Pharmacy
  • $15,000 Jul 20, 2016 Issue: Health Issues
  • $30,000 Apr 20, 2016 Issue: Pharmacy
  • $15,000 Apr 19, 2016 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for HRTX

13 former government officials from 7 congressional offices at 3 lobbying firms have lobbied for HRTX, most recently Jul 20, 2026.

  • Ed Whitfield
    Jeffery Mortier House Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes Formerly with Ed Whitfield · FARRAGUT PARTNERS LLP · Jul 20, 2026
  • Edward Whitfield Congress Member of Congress (KY 01), 21 yrs. Formerly Member of Congress (KY 01), 21 yrs. · FARRAGUT PARTNERS LLP · Jul 20, 2026
  • John B. Breaux
    Sarah Walter Senate Former Legislative Director/Chief Counsel, Sen. John Breaux Formerly with John B. Breaux · FARRAGUT PARTNERS LLP · Jul 20, 2026
  • Joe Barton
    Jeff Mackinnon House LD and LA Rep. Joe Barton (R-Texas) Formerly with Joe Barton · FARRAGUT PARTNERS LLP · Jul 20, 2026
  • Kristen Bautz House Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz Formerly Wasserman Shultz · FARRAGUT PARTNERS LLP · Jul 20, 2026
  • John A. Boehner
    Dylan Moore House Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10) Formerly with John A. Boehner · FARRAGUT PARTNERS LLP · Jul 20, 2026
  • Daniel Coats
    Constantine Hingson Senate New Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole Formerly with Daniel Coats · FARRAGUT PARTNERS LLP · Jul 20, 2026
  • Wayne T. Gilchrest
    J Walsh House LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner Formerly with Wayne T. Gilchrest · FARRAGUT PARTNERS LLP · Oct 28, 2022
See all 13 on the Revolving Door dashboard
Corporate Lobbying

HRTX Estimated quarterly lobbying spending

Revenue Breakdown

HRTX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
HRTX Income Statement
HRTX Balance Sheet
HRTX Cash Flow
U.S. Patents

New HRTX patent grants

  • Patent Title: Compositions of a polyorthoester and an aprotic solvent Jun. 03, 2025
  • Patent Title: Methods of use of emulsion formulations of aprepitant May. 06, 2025
  • Patent Title: Methods of use of emulsion formulations of an nk-1 receptor antagonist Oct. 15, 2024
  • Patent Title: Methods of use of emulsion formulations of an nk-1 receptor antagonist Oct. 15, 2024
  • Patent Title: Methods of use of emulsion formulations of an nk-1 receptor antagonist Jan. 23, 2024
  • Patent Title: Compositions of a polyorthoester and an organic acid excipient Dec. 19, 2023
  • Patent Title: Methods of use of emulsion formulations of an nk-1 receptor antagonist Sep. 05, 2023
  • Patent Title: Long-acting polymeric delivery systems Aug. 16, 2022
  • Patent Title: Compositions of a polyorthoester and an aprotic solvent Feb. 22, 2022
  • Patent Title: Emulsion formulations of an nk-1 receptor antagonist and uses thereof Nov. 16, 2021
  • Patent Title: Long-acting polymeric delivery systems Aug. 10, 2021
  • Patent Title: Long-acting polymeric delivery systems Aug. 10, 2021
  • Patent Title: Compositions of a polyorthoester and an organic acid excipient Apr. 20, 2021
  • Patent Title: Emulsion formulations of aprepitant Mar. 23, 2021
  • Patent Title: Long-acting polymeric delivery systems Jan. 26, 2021
  • Patent Title: Emulsion formulations of aprepitant Dec. 10, 2019
  • Patent Title: Compositions of a polyorthoester and an aprotic solvent Sep. 03, 2019
  • Patent Title: Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron Jul. 23, 2019
  • Patent Title: Long-acting polymeric delivery systems Feb. 26, 2019
  • Patent Title: Long-acting polymeric delivery systems Oct. 16, 2018
  • Patent Title: Emulsion formulations of aprepitant May. 22, 2018
  • Patent Title: Emulsion formulations of aprepitant May. 22, 2018
  • Patent Title: Emulsion formulations of an nk-1 receptor antagonist and uses thereof May. 22, 2018
  • Patent Title: Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron Mar. 13, 2018
  • Patent Title: Compositions of a polyorthoester and an aprotic solvent Mar. 13, 2018
  • Patent Title: Emulsion formulations of aprepitant Nov. 07, 2017
  • Patent Title: Long-acting polymeric delivery systems Oct. 31, 2017
  • Patent Title: Compositions of a polyorthoester and an aprotic solvent Aug. 29, 2017
  • Patent Title: Long-acting polymeric delivery systems Jul. 04, 2017
  • Patent Title: Compositions of a polyorthoester and an aprotic solvent Mar. 14, 2017
  • Patent Title: Emulsion formulations of aprepitant Feb. 07, 2017
  • Patent Title: Compositions of a polyorthoester and an aprotic solvent Sep. 20, 2016
  • Patent Title: Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron May. 06, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to HRTX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
HRTX News

Recent insights relating to HRTX

CNBC Recommendations

Recent picks made for HRTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HRTX

HRTX Analyst Ratings

HRTX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
HRTX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $HRTX stock a Buy, Sell, or Hold?

  • What is the price target for $HRTX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

HRTX Top Shareholders
Shareholder
Shares Held
HRTX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $HRTX stock?

  • Who owns the most shares of $HRTX stock?

  • What funds own $HRTX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

HRTX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view HRTX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About HRTX

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

  • Address San Diego, CA
  • Market Cap 56.8 million
  • Employees 128
  • Industrial Classification Pharmaceutical Preparations

Heron Therapeutics, Inc. (HRTX) Historical Stock Prices

Heron Therapeutics, Inc. (HRTX) closed at $0.2990 on September 22, 2026. Over the past year its adjusted close ranged from $0.2700 to $1.49. Daily prices go back to January 23, 2014, 3,185 trading days in all.

  • 1 month-6.03%
  • 3 months-28.57%
  • Year to date-77.00%
  • 1 year-77.00%
  • 3 years-70.40%
  • 5 years-97.65%
  • Max-97.65%
See every congressional and insider trade on the HRTX price chart

Quiver Premium charts HRTX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 0.2771 0.3060 0.2716 0.2990 0.2990 3,870,635
Sep 21, 2026 0.3100 0.3102 0.2610 0.2700 0.2700 8,585,585
Sep 18, 2026 0.3162 0.3171 0.3075 0.3097 0.3097 3,953,162
Sep 17, 2026 0.3300 0.3300 0.3070 0.3157 0.3157 916,759
Sep 16, 2026 0.3154 0.3210 0.3101 0.3178 0.3178 1,106,476
Sep 15, 2026 0.3095 0.3168 0.3060 0.3140 0.3140 1,495,509
Sep 14, 2026 0.3155 0.3199 0.3070 0.3153 0.3153 1,174,406
Sep 11, 2026 0.3300 0.3312 0.3114 0.3155 0.3155 1,371,704
Sep 10, 2026 0.3300 0.3311 0.3207 0.3223 0.3223 1,125,200
Sep 9, 2026 0.3427 0.3507 0.3300 0.3330 0.3330 1,794,165
Sep 8, 2026 0.3479 0.3550 0.3300 0.3500 0.3500 1,056,572
Sep 4, 2026 0.3375 0.3550 0.3253 0.3439 0.3439 1,878,452
Sep 3, 2026 0.3270 0.3337 0.3106 0.3300 0.3300 1,314,567
Sep 2, 2026 0.3110 0.3280 0.3061 0.3129 0.3129 2,170,209
Sep 1, 2026 0.3180 0.3300 0.3016 0.3150 0.3150 2,375,176
Aug 31, 2026 0.3370 0.3370 0.3140 0.3180 0.3180 2,132,633
Aug 28, 2026 0.3300 0.3350 0.3175 0.3266 0.3266 953,134
Aug 27, 2026 0.3180 0.3415 0.3108 0.3321 0.3321 1,872,060
Aug 26, 2026 0.3201 0.3290 0.3029 0.3122 0.3122 3,096,188
Aug 25, 2026 0.3360 0.3388 0.3178 0.3231 0.3231 1,625,294
Aug 24, 2026 0.3200 0.3295 0.3000 0.3228 0.3228 2,298,912
Aug 21, 2026 0.3106 0.3330 0.3100 0.3182 0.3182 3,015,205
Aug 20, 2026 0.3200 0.3200 0.2975 0.3090 0.3090 1,975,701
Aug 19, 2026 0.3200 0.3269 0.3050 0.3149 0.3149 3,137,771
Aug 18, 2026 0.3100 0.3152 0.3000 0.3009 0.3009 4,123,150
Aug 17, 2026 0.3500 0.3500 0.3110 0.3200 0.3200 2,816,084
Aug 14, 2026 0.3401 0.3476 0.3282 0.3367 0.3367 1,762,099
Aug 13, 2026 0.3410 0.3588 0.3216 0.3344 0.3344 3,321,297
Aug 12, 2026 0.3233 0.3596 0.3067 0.3409 0.3409 3,588,687
Aug 11, 2026 0.3334 0.3350 0.3030 0.3238 0.3238 9,770,246
Aug 10, 2026 0.4226 0.4226 0.3246 0.3350 0.3350 11,669,598
Aug 7, 2026 0.4954 0.5194 0.4704 0.4908 0.4908 2,131,205
Aug 6, 2026 0.4803 0.5245 0.4800 0.4990 0.4990 1,712,621
Aug 5, 2026 0.5092 0.5102 0.4944 0.5048 0.5048 1,320,960
Aug 4, 2026 0.5107 0.5399 0.5092 0.5115 0.5115 1,461,046
Aug 3, 2026 0.5100 0.5200 0.4973 0.5114 0.5114 1,506,032
Jul 31, 2026 0.5000 0.5179 0.4803 0.4962 0.4962 1,338,498
Jul 30, 2026 0.4900 0.5177 0.4898 0.4974 0.4974 965,767
Jul 29, 2026 0.4943 0.5098 0.4828 0.4935 0.4935 1,500,638
Jul 28, 2026 0.4603 0.4964 0.4500 0.4859 0.4859 1,683,176
Jul 27, 2026 0.4700 0.4896 0.4523 0.4592 0.4592 2,211,885
Jul 24, 2026 0.4530 0.4642 0.4500 0.4558 0.4558 1,159,366
Jul 23, 2026 0.4603 0.4777 0.4500 0.4590 0.4590 1,265,339
Jul 22, 2026 0.4811 0.5029 0.4650 0.4676 0.4676 1,401,515
Jul 21, 2026 0.4881 0.4918 0.4605 0.4772 0.4772 1,548,562
Jul 20, 2026 0.4749 0.4897 0.4675 0.4804 0.4804 1,290,967
Jul 17, 2026 0.4739 0.4999 0.4659 0.4707 0.4707 1,677,912
Jul 16, 2026 0.4400 0.4971 0.4301 0.4760 0.4760 5,543,338
Jul 15, 2026 0.4300 0.4471 0.4108 0.4390 0.4390 3,046,347
Jul 14, 2026 0.4177 0.4420 0.4000 0.4299 0.4299 3,548,206
Jul 13, 2026 0.4100 0.4200 0.3944 0.4169 0.4169 6,180,285
Jul 10, 2026 0.4250 0.4399 0.4007 0.4144 0.4144 2,714,660
Jul 9, 2026 0.4499 0.4545 0.4231 0.4285 0.4285 1,569,333
Jul 8, 2026 0.4250 0.4455 0.4229 0.4455 0.4455 3,346,611
Jul 7, 2026 0.4300 0.4381 0.4112 0.4257 0.4257 2,632,214
Jul 6, 2026 0.4300 0.4477 0.4151 0.4339 0.4339 2,630,878
Jul 2, 2026 0.4400 0.4495 0.4194 0.4384 0.4384 3,064,970
Jul 1, 2026 0.4200 0.4435 0.4200 0.4244 0.4244 3,775,640
Jun 30, 2026 0.4371 0.4538 0.4194 0.4268 0.4268 3,180,009
Jun 29, 2026 0.4330 0.4402 0.4276 0.4355 0.4355 1,986,587
Jun 26, 2026 0.4051 0.4300 0.4050 0.4300 0.4300 6,428,234
Jun 25, 2026 0.4394 0.4468 0.4083 0.4100 0.4100 2,426,583
Jun 24, 2026 0.4150 0.4584 0.4135 0.4333 0.4333 3,628,512
Jun 23, 2026 0.4158 0.4343 0.4133 0.4186 0.4186 2,893,205
Jun 22, 2026 0.4170 0.4462 0.4100 0.4286 0.4286 4,814,190
Jun 18, 2026 0.3976 0.4180 0.3909 0.4175 0.4175 5,463,114
Jun 17, 2026 0.3902 0.4050 0.3851 0.3873 0.3873 3,371,101
Jun 16, 2026 0.4100 0.4150 0.3820 0.3820 0.3820 2,824,004
Jun 15, 2026 0.4200 0.4211 0.4000 0.4041 0.4041 3,952,885
Jun 12, 2026 0.4078 0.4148 0.3967 0.4001 0.4001 4,558,207
Jun 11, 2026 0.4000 0.4200 0.3900 0.4059 0.4059 5,242,904
Jun 10, 2026 0.4100 0.4200 0.4020 0.4084 0.4084 4,127,798
Jun 9, 2026 0.4582 0.4596 0.4000 0.4049 0.4049 4,387,510
Jun 8, 2026 0.4468 0.4742 0.4400 0.4536 0.4536 2,595,787
Jun 5, 2026 0.4761 0.4840 0.4199 0.4274 0.4274 4,394,470
Jun 4, 2026 0.4412 0.5062 0.4402 0.4835 0.4835 5,002,769
Jun 3, 2026 0.4774 0.5185 0.4275 0.4468 0.4468 10,825,483
Jun 2, 2026 0.6750 0.6900 0.4484 0.4500 0.4500 22,019,253
Jun 1, 2026 0.8761 0.8790 0.8200 0.8272 0.8272 2,639,343
May 29, 2026 0.8730 0.8900 0.8501 0.8701 0.8701 1,832,479
May 28, 2026 0.8996 0.8996 0.8630 0.8919 0.8919 1,711,210
May 27, 2026 0.8848 0.9274 0.8810 0.9098 0.9098 1,646,403
May 26, 2026 0.8585 0.8896 0.8415 0.8833 0.8833 1,607,283
May 22, 2026 0.8800 0.8953 0.8543 0.8588 0.8588 1,049,775
May 21, 2026 0.8422 0.8844 0.8362 0.8712 0.8712 1,872,447
May 20, 2026 0.8597 0.8635 0.8336 0.8451 0.8451 2,120,321
May 19, 2026 0.8600 0.8873 0.8400 0.8481 0.8481 2,023,348
May 18, 2026 0.8500 0.8832 0.8402 0.8594 0.8594 1,616,029
May 15, 2026 0.9300 0.9343 0.8500 0.8500 0.8500 1,988,414
May 14, 2026 0.9125 0.9379 0.9080 0.9124 0.9124 1,810,221
May 13, 2026 0.9640 0.9800 0.9144 0.9144 0.9144 2,425,605
May 12, 2026 0.9643 1.00 0.9302 0.9642 0.9642 2,364,928
May 11, 2026 1.09 1.09 0.9000 0.9553 0.9553 8,533,103
May 8, 2026 1.25 1.25 1.21 1.21 1.21 1,794,647
May 7, 2026 1.30 1.30 1.22 1.24 1.24 1,344,705
May 6, 2026 1.24 1.34 1.21 1.31 1.31 4,618,439
May 5, 2026 1.23 1.24 1.19 1.23 1.23 1,740,737
May 4, 2026 1.29 1.30 1.20 1.22 1.22 2,118,810
May 1, 2026 1.22 1.30 1.19 1.27 1.27 2,705,757
Apr 30, 2026 1.20 1.21 1.16 1.20 1.20 1,060,531
Apr 29, 2026 1.22 1.22 1.16 1.19 1.19 1,321,620
Apr 28, 2026 1.20 1.25 1.19 1.21 1.21 2,010,182
Apr 27, 2026 1.20 1.28 1.18 1.19 1.19 3,974,351
Apr 24, 2026 0.9965 1.22 0.9703 1.19 1.19 6,080,717
Apr 23, 2026 1.01 1.01 0.9696 0.9998 0.9998 1,973,072
Apr 22, 2026 1.04 1.06 1.02 1.02 1.02 1,385,418
Apr 21, 2026 1.05 1.10 1.01 1.02 1.02 2,406,215
Apr 20, 2026 1.02 1.05 0.9876 1.05 1.05 1,356,436
Apr 17, 2026 0.9649 1.03 0.9501 1.00 1.00 2,631,168
Apr 16, 2026 0.9596 0.9596 0.9300 0.9400 0.9400 1,358,098
Apr 15, 2026 0.9451 0.9650 0.9400 0.9567 0.9567 1,661,036
Apr 14, 2026 0.9123 0.9800 0.9100 0.9371 0.9371 2,705,897
Apr 13, 2026 0.8528 0.9100 0.8200 0.9067 0.9067 1,598,165
Apr 10, 2026 0.8257 0.8700 0.8257 0.8530 0.8530 2,044,175
Apr 9, 2026 0.8256 0.8300 0.8000 0.8194 0.8194 1,617,921
Apr 8, 2026 0.8406 0.8500 0.8107 0.8320 0.8320 1,234,088
Apr 7, 2026 0.8068 0.8135 0.7649 0.7894 0.7894 1,229,356
Apr 6, 2026 0.8000 0.8633 0.8000 0.8105 0.8105 1,424,992
Apr 2, 2026 0.7859 0.8084 0.7700 0.7992 0.7992 913,792
Apr 1, 2026 0.8200 0.8200 0.7815 0.8035 0.8035 1,114,075
Mar 31, 2026 0.7400 0.8100 0.7400 0.8001 0.8001 1,238,233
Mar 30, 2026 0.8000 0.8019 0.7362 0.7459 0.7459 1,534,168
Mar 27, 2026 0.8157 0.8157 0.7645 0.7837 0.7837 1,901,319
Mar 26, 2026 0.7998 0.8740 0.7800 0.8251 0.8251 7,329,127
Mar 25, 2026 0.7700 0.8084 0.7617 0.7963 0.7963 1,825,655
Mar 24, 2026 0.8000 0.8240 0.7510 0.7645 0.7645 1,505,973
Mar 23, 2026 0.8044 0.8568 0.7804 0.7996 0.7996 1,084,908
Mar 20, 2026 0.8200 0.8241 0.7650 0.7786 0.7786 2,039,536
Mar 19, 2026 0.8200 0.8680 0.7964 0.8173 0.8173 1,527,416
Mar 18, 2026 0.8510 0.8600 0.8210 0.8400 0.8400 2,169,223
Mar 17, 2026 0.8975 0.9300 0.8410 0.8663 0.8663 2,207,444
Mar 16, 2026 0.8958 0.9163 0.8789 0.8972 0.8972 1,669,263
Mar 13, 2026 0.9600 0.9600 0.8800 0.8817 0.8817 2,114,971
Mar 12, 2026 0.9700 0.9700 0.9200 0.9279 0.9279 1,111,808
Mar 11, 2026 0.9924 0.9999 0.9581 0.9700 0.9700 1,056,913
Mar 10, 2026 0.9970 1.04 0.9666 0.9882 0.9882 1,485,482
Mar 9, 2026 0.9200 1.01 0.9092 0.9965 0.9965 1,651,219
Mar 6, 2026 1.03 1.05 0.9500 0.9666 0.9666 3,651,360
Mar 5, 2026 1.12 1.14 1.01 1.02 1.02 3,102,048
Mar 4, 2026 1.17 1.19 1.13 1.13 1.13 1,074,717
Mar 3, 2026 1.17 1.23 1.15 1.15 1.15 2,120,989
Mar 2, 2026 1.17 1.25 1.14 1.20 1.20 1,892,725
Feb 27, 2026 1.19 1.21 1.14 1.19 1.19 2,155,587
Feb 26, 2026 1.24 1.33 1.13 1.20 1.20 8,343,487
Feb 25, 2026 1.14 1.17 1.05 1.08 1.08 5,147,606
Feb 24, 2026 1.21 1.22 1.07 1.09 1.09 2,688,363
Feb 23, 2026 1.18 1.22 1.17 1.19 1.19 1,302,206
Feb 20, 2026 1.20 1.21 1.16 1.18 1.18 839,116
Feb 19, 2026 1.20 1.22 1.18 1.19 1.19 325,217
Feb 18, 2026 1.20 1.24 1.17 1.21 1.21 697,781
Feb 17, 2026 1.16 1.23 1.15 1.19 1.19 1,449,236
Feb 13, 2026 1.17 1.21 1.14 1.15 1.15 633,881
Feb 12, 2026 1.21 1.22 1.11 1.15 1.15 1,092,918
Feb 11, 2026 1.25 1.26 1.17 1.17 1.17 1,893,810
Feb 10, 2026 1.28 1.30 1.27 1.27 1.27 595,072
Feb 9, 2026 1.24 1.28 1.22 1.28 1.28 631,586
Feb 6, 2026 1.22 1.28 1.19 1.26 1.26 1,139,187
Feb 5, 2026 1.32 1.32 1.19 1.21 1.21 990,885
Feb 4, 2026 1.37 1.38 1.30 1.32 1.32 1,428,140
Feb 3, 2026 1.38 1.39 1.34 1.37 1.37 994,197
Feb 2, 2026 1.32 1.42 1.32 1.38 1.38 933,350
Jan 30, 2026 1.33 1.34 1.31 1.32 1.32 691,444
Jan 29, 2026 1.33 1.35 1.31 1.34 1.34 925,657
Jan 28, 2026 1.39 1.39 1.31 1.33 1.33 1,190,384
Jan 27, 2026 1.44 1.44 1.38 1.40 1.40 834,087
Jan 26, 2026 1.42 1.45 1.41 1.44 1.44 710,371
Jan 23, 2026 1.44 1.46 1.41 1.42 1.42 1,085,571
Jan 22, 2026 1.46 1.49 1.44 1.45 1.45 941,995
Jan 21, 2026 1.42 1.50 1.42 1.46 1.46 1,431,738
Jan 20, 2026 1.46 1.48 1.42 1.42 1.42 1,167,595
Jan 16, 2026 1.49 1.52 1.46 1.49 1.49 808,838
Jan 15, 2026 1.49 1.51 1.45 1.49 1.49 936,134
Jan 14, 2026 1.48 1.51 1.46 1.49 1.49 665,641
Jan 13, 2026 1.50 1.50 1.43 1.48 1.48 1,784,612
Jan 12, 2026 1.40 1.57 1.40 1.49 1.49 3,921,324
Jan 9, 2026 1.28 1.57 1.28 1.39 1.39 7,602,138
Jan 8, 2026 1.26 1.30 1.25 1.27 1.27 1,168,607
Jan 7, 2026 1.22 1.29 1.22 1.26 1.26 1,277,642
Jan 6, 2026 1.24 1.26 1.20 1.22 1.22 1,285,733
Jan 5, 2026 1.27 1.28 1.18 1.24 1.24 1,845,462
Jan 2, 2026 1.30 1.32 1.22 1.26 1.26 2,308,309
Dec 31, 2025 1.30 1.34 1.29 1.30 1.30 1,173,851
Dec 30, 2025 1.29 1.39 1.29 1.35 1.35 1,913,441
Dec 29, 2025 1.27 1.33 1.25 1.31 1.31 1,959,555
Dec 26, 2025 1.28 1.31 1.27 1.28 1.28 899,332
Dec 24, 2025 1.27 1.30 1.26 1.28 1.28 585,543
Dec 23, 2025 1.34 1.34 1.27 1.28 1.28 1,235,312
Dec 22, 2025 1.29 1.40 1.28 1.34 1.34 1,755,937
Dec 19, 2025 1.29 1.32 1.26 1.30 1.30 3,172,874
Dec 18, 2025 1.28 1.31 1.26 1.29 1.29 1,603,491
Dec 17, 2025 1.41 1.41 1.13 1.27 1.27 2,885,083
Dec 16, 2025 1.40 1.42 1.36 1.38 1.38 1,704,883
Dec 15, 2025 1.36 1.44 1.32 1.40 1.40 2,528,054
Dec 12, 2025 1.36 1.40 1.34 1.37 1.37 1,904,441
Dec 11, 2025 1.36 1.39 1.35 1.37 1.37 1,665,979
Dec 10, 2025 1.33 1.38 1.32 1.37 1.37 2,461,267
Dec 9, 2025 1.35 1.36 1.30 1.33 1.33 1,623,050
Dec 8, 2025 1.32 1.36 1.27 1.35 1.35 2,436,581
Dec 5, 2025 1.29 1.34 1.26 1.31 1.31 1,708,551
Dec 4, 2025 1.27 1.32 1.20 1.31 1.31 2,743,836
Dec 3, 2025 1.17 1.28 1.15 1.27 1.27 2,596,375
Dec 2, 2025 1.16 1.18 1.12 1.17 1.17 1,700,186
Dec 1, 2025 1.15 1.17 1.10 1.15 1.15 2,566,759
Nov 28, 2025 1.12 1.17 1.11 1.16 1.16 770,761
Nov 26, 2025 1.08 1.13 1.07 1.12 1.12 1,900,419
Nov 25, 2025 1.13 1.14 1.07 1.09 1.09 2,022,991
Nov 24, 2025 1.07 1.13 1.05 1.13 1.13 1,934,680
Nov 21, 2025 1.03 1.07 1.01 1.06 1.06 2,110,658
Nov 20, 2025 1.10 1.14 1.04 1.05 1.05 2,770,343
Nov 19, 2025 1.12 1.12 0.9999 1.09 1.09 4,104,701
Nov 18, 2025 1.09 1.12 1.04 1.12 1.12 2,080,245
Nov 17, 2025 1.12 1.14 1.07 1.09 1.09 1,346,215
Nov 14, 2025 1.11 1.12 1.10 1.10 1.10 1,099,740
Nov 13, 2025 1.10 1.12 1.09 1.11 1.11 1,636,532
Nov 12, 2025 1.16 1.16 1.10 1.11 1.11 1,075,890
Nov 11, 2025 1.11 1.16 1.08 1.16 1.16 1,345,038
Nov 10, 2025 1.10 1.11 1.08 1.11 1.11 1,743,686
Nov 7, 2025 1.11 1.12 1.05 1.10 1.10 2,315,627
Nov 6, 2025 1.10 1.12 1.07 1.10 1.10 1,346,277
Nov 5, 2025 1.12 1.14 1.06 1.11 1.11 1,543,683
Nov 4, 2025 1.17 1.19 1.07 1.14 1.14 5,679,820
Nov 3, 2025 1.18 1.28 1.09 1.18 1.18 4,924,156
Oct 31, 2025 1.15 1.20 1.14 1.16 1.16 1,732,483
Oct 30, 2025 1.15 1.21 1.14 1.14 1.14 1,745,065
Oct 29, 2025 1.18 1.20 1.16 1.17 1.17 1,780,048
Oct 28, 2025 1.17 1.22 1.17 1.19 1.19 1,628,709
Oct 27, 2025 1.21 1.25 1.17 1.18 1.18 1,788,820
Oct 24, 2025 1.20 1.24 1.16 1.20 1.20 2,788,760
Oct 23, 2025 1.20 1.22 1.17 1.19 1.19 1,954,220
Oct 22, 2025 1.30 1.31 1.17 1.19 1.19 2,585,952
Oct 21, 2025 1.35 1.36 1.29 1.30 1.30 1,957,316
Oct 20, 2025 1.30 1.36 1.30 1.35 1.35 729,641
Oct 17, 2025 1.30 1.32 1.28 1.29 1.29 640,734
Oct 16, 2025 1.34 1.38 1.29 1.30 1.30 977,814
Oct 15, 2025 1.32 1.37 1.31 1.35 1.35 1,017,934
Oct 14, 2025 1.28 1.33 1.27 1.32 1.32 848,835
Oct 13, 2025 1.29 1.33 1.28 1.30 1.30 766,125
Oct 10, 2025 1.31 1.33 1.27 1.28 1.28 1,615,227
Oct 9, 2025 1.37 1.37 1.31 1.31 1.31 1,257,473
Oct 8, 2025 1.33 1.39 1.31 1.35 1.35 1,310,152
Oct 7, 2025 1.34 1.35 1.30 1.32 1.32 1,322,205
Oct 6, 2025 1.33 1.36 1.29 1.34 1.34 1,538,266
Oct 3, 2025 1.30 1.37 1.29 1.32 1.32 2,156,236
Oct 2, 2025 1.25 1.33 1.23 1.30 1.30 2,082,804
Oct 1, 2025 1.26 1.28 1.24 1.25 1.25 1,424,635
Sep 30, 2025 1.26 1.28 1.24 1.26 1.26 1,194,625
Sep 29, 2025 1.22 1.28 1.21 1.27 1.27 1,280,398
Sep 26, 2025 1.22 1.25 1.18 1.21 1.21 4,080,609
Sep 25, 2025 1.23 1.25 1.21 1.22 1.22 1,558,080
Sep 24, 2025 1.26 1.26 1.24 1.25 1.25 1,068,323
Sep 23, 2025 1.30 1.31 1.24 1.24 1.24 1,674,879
Sep 22, 2025 1.22 1.30 1.21 1.30 1.30 1,496,483

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Heron Therapeutics, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at HRTX, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation